- Report
- August 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- August 2024
- 100 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- March 2025
- 193 Pages
Global
From €4699EUR$4,950USD£3,964GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- September 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- May 2024
- 163 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- February 2025
- 185 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- February 2025
- 184 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- January 2025
- 133 Pages
Europe
From €3797EUR$4,000USD£3,203GBP
- Report
- November 2023
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- January 2024
- 150 Pages
Global
From €4604EUR$4,850USD£3,884GBP
- Report
- September 2021
- 99 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- February 2024
- 110 Pages
Global
From €4509EUR$4,750USD£3,804GBP
- Report
- July 2023
- 145 Pages
Global
From €2990EUR$3,150USD£2,522GBP
- Report
- May 2023
- 74 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Drug Pipelines
- November 2020
- 35 Pages
Global
From €1899EUR$2,000USD£1,602GBP
- Report
- December 2023
- 300 Pages
Global
From €2373EUR$2,500USD£2,002GBP
From €1424EUR$1,500USD£1,201GBP
- Report
- December 2023
- 80 Pages
South Korea
From €1424EUR$1,500USD£1,201GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €1424EUR$1,500USD£1,201GBP

Levothyroxine is a synthetic thyroid hormone used to treat hypothyroidism, a condition in which the thyroid gland does not produce enough thyroid hormone. It is a part of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat a variety of conditions related to hormones and metabolism. These drugs are used to treat conditions such as diabetes, obesity, and thyroid disorders. Levothyroxine is the most commonly prescribed drug in this market, as it is used to treat the most common form of hypothyroidism.
Levothyroxine is available in both generic and brand-name forms. Generic levothyroxine is widely available and is often the preferred option due to its lower cost. Brand-name levothyroxine is more expensive but may be preferred by some patients due to its higher quality.
Some companies in the Levothyroxine market include AbbVie, Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more